167 related articles for article (PubMed ID: 1613561)
1. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
Knuuti MJ; Nuutila P; Ruotsalainen U; Saraste M; Härkönen R; Ahonen A; Teräs M; Haaparanta M; Wegelius U; Haapanen A
J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
[TBL] [Abstract][Full Text] [Related]
2. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET.
Knuuti MJ; Nuutila P; Ruotsalainen U; Teräs M; Saraste M; Härkönen R; Ahonen A; Wegelius U; Haapanen A; Bergman J
J Nucl Med; 1993 Dec; 34(12):2068-75. PubMed ID: 8254389
[TBL] [Abstract][Full Text] [Related]
3. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
Schelbert HR
J Nucl Med; 1992 Jul; 33(7):1263-6. PubMed ID: 1613562
[No Abstract] [Full Text] [Related]
4. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
[TBL] [Abstract][Full Text] [Related]
6. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
[TBL] [Abstract][Full Text] [Related]
7. Myocardial 18F-FDG-PET. Experiences with the euglycemic hyperinsulinemic clamp technique.
Locher JT; Frey LD; Seybold K; Jenzer H
Angiology; 1995 Apr; 46(4):313-20. PubMed ID: 7726451
[TBL] [Abstract][Full Text] [Related]
8. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
Ohtake T; Yokoyama I; Watanabe T; Momose T; Serezawa T; Nishikawa J; Sasaki Y
J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509
[TBL] [Abstract][Full Text] [Related]
9. Simplified PET quantitation of myocardial glucose utilization.
Nakagawa K; Namba H; Iyo M; Fukushi K; Irie T; Yamanouchi M; Shikama N; Himi T; Yoshida K; Masuda Y
J Nucl Med; 1995 Nov; 36(11):2094-102. PubMed ID: 7472605
[TBL] [Abstract][Full Text] [Related]
10. Myocardial FDG PET studies with the fasting, oral glucose-loading or insulin clamp methods.
Tamaki N; Yonekura Y; Konishi J
J Nucl Med; 1992 Jul; 33(7):1263, 1266-8. PubMed ID: 1613563
[No Abstract] [Full Text] [Related]
11. Effect of nicotinic acid on exogenous myocardial glucose utilization.
Stone CK; Holden JE; Stanley W; Perlman SB
J Nucl Med; 1995 Jun; 36(6):996-1002. PubMed ID: 7769458
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
Herrero P; Sharp TL; Dence C; Haraden BM; Gropler RJ
J Nucl Med; 2002 Nov; 43(11):1530-41. PubMed ID: 12411556
[TBL] [Abstract][Full Text] [Related]
13. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose.
Gambhir SS; Schwaiger M; Huang SC; Krivokapich J; Schelbert HR; Nienaber CA; Phelps ME
J Nucl Med; 1989 Mar; 30(3):359-66. PubMed ID: 2786939
[TBL] [Abstract][Full Text] [Related]
14. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.
Bax JJ; Veening MA; Visser FC; van Lingen A; Heine RJ; Cornel JH; Visser CA
Eur J Nucl Med; 1997 Jan; 24(1):35-41. PubMed ID: 9044874
[TBL] [Abstract][Full Text] [Related]
15. Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18F-fluorodeoxyglucose gated PET cardiac imaging: comparative results.
Schröder O; Hör G; Hertel A; Baum RP
Nucl Med Commun; 1998 Sep; 19(9):867-74. PubMed ID: 10581593
[TBL] [Abstract][Full Text] [Related]
16. The effect of insulin and FFA on myocardial glucose uptake.
Knuuti MJ; Mäki M; Yki-Järvinen H; Voipio-Pulkki LM; Härkönen R; Haaparanta M; Nuutila P
J Mol Cell Cardiol; 1995 Jul; 27(7):1359-67. PubMed ID: 7473782
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.
Choi Y; Brunken RC; Hawkins RA; Huang SC; Buxton DB; Hoh CK; Phelps ME; Schelbert HR
Eur J Nucl Med; 1993 Apr; 20(4):308-18. PubMed ID: 8491223
[TBL] [Abstract][Full Text] [Related]
18. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J
J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154
[TBL] [Abstract][Full Text] [Related]
19. [The recent studies of myocardial blood flow and metabolism by using positron emission computed tomography].
Ohtake T; Yokoyama I; Serizawa T; Nishikawa J; Sasaki Y
Kaku Igaku; 1993 Mar; 30(3):331-9. PubMed ID: 8479102
[TBL] [Abstract][Full Text] [Related]
20. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
